Company Search:
Advanced Search
Sponsored Links
Carl Zeiss Meditec AG Company Snapshot
Carl Zeiss Meditec AG operates in the Computer integrated systems design sector. In addition to historical fundamental analyses, the complete report available to purchase compares Carl Zeiss Meditec AG with three other companies in this sector in Germany: Euromicron AG (2017 sales of 332.91 million Euro [US$388.46 million] of which 57% was Smart buildings), GFT Technologies SE (418.81 million Euro [US$488.69 million] of which 53% was GFT Continental Europe), and Cancom SE (1.16 billion Euro [US$1.36 billion] of which 84% was IT Solutions).

Sales Analysis. Carl Zeiss Meditec AG reported sales of 1.19 billion Euro (US$1.39 billion) for the fiscal year ending September of 2017. This represents an increase of 9.3% versus 2016, when the company's sales were 1.09 billion Euro. Sales at Carl Zeiss Meditec AG have increased during each of the previous five years (and since 2012, sales have increased a total of 38%). Sales of Ophthalmic Systems saw an increase that was more than double the company's growth rate: sales were up 109.0% in 2017, from 421.18 million Euro to 880.46 million Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Carl Zeiss Meditec AG
  Stock Performance Chart for Carl Zeiss Meditec AG
  Stock Data: Recent Stock Performance:
  Current Price (9/21/2018): 74.60
(Figures in Euro)
1 Week -1.8%   13 Weeks -0.1%  
4 Weeks 24.9%   52 Weeks 77.4%  
Carl Zeiss Meditec AG Key Data:
  Ticker: AFX Country: Germany
  Exchanges: DUS Major Industry: Software & Services
    Sub Industry: Computer Integrated Systems Design
  2017 Sales 1,189,896,000
(Year Ending Jan 2018).
Employees: 2,958
  Currency: Euro Market Cap: 6,672,266,522
  Fiscal Yr Ends: September Shares Outstanding: 89,440,570
  Share Type: Stammaktie Closely Held Shares: 52,851,500
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.